![Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumab]()
Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumabRogatsch, Max; Schmid, Johannes; Lax, Sigurd; Uranitsch, Maximilian; Schmid-Zalaudek, Karin; Giuffrida, Roberta; Zalaudek, Iris · European Journal of Cancer · 2017